Data as of Jul 29
| +0.02 / +1.25%|
The 2 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +208.64% increase from the last price of 1.62.
The current consensus among 2 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.